Search research articles
Contact Us
Filters
Showing results (391-400 of 589) with videos related to
Page
of 59
Sort By:
Journal of Neuro-Oncology
|
April 17, 2024
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines
Daniela Kocher, Lei Cao, Romain Guiho, et al.
Acta Neuropathologica
|
July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations
Philipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica
|
September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers, Damian Stichel, Martin Sill, et al.
Neuro-Oncology
|
June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Chris Jones, Matthias A Karajannis, David T W Jones, et al.
Nature Communications
|
October 4, 2024
Author Correction: Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
David R Ghasemi, Konstantin Okonechnikov, Anne Rademacher, et al.
Neuropathology and Applied Neurobiology
|
December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data
Damian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal of Personalized Medicine
|
December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma
Lisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
The Lancet. Oncology
|
April 20, 2013
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, et al.
Acta Neuropathologica
|
March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma
Huriye Cin, Claus Meyer, Ricarda Herr, et al.
Acta Neuropathologica
|
February 19, 2013
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M Fontebasso, Jeremy Schwartzentruber, Dong-Anh Khuong-Quang, et al.
Page
of 59
Search research articles
Search
Showing results (391-400 of 589) with videos related to
Sort By:
Page
of 59
Journal of Neuro-Oncology
|
April 17, 2024
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines
Daniela Kocher, Lei Cao, Romain Guiho, et al.
Acta Neuropathologica
|
July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations
Philipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica
|
September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers, Damian Stichel, Martin Sill, et al.
Neuro-Oncology
|
June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Chris Jones, Matthias A Karajannis, David T W Jones, et al.
Nature Communications
|
October 4, 2024
Author Correction: Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
David R Ghasemi, Konstantin Okonechnikov, Anne Rademacher, et al.
Neuropathology and Applied Neurobiology
|
December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data
Damian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal of Personalized Medicine
|
December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma
Lisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
The Lancet. Oncology
|
April 20, 2013
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, et al.
Acta Neuropathologica
|
March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma
Huriye Cin, Claus Meyer, Ricarda Herr, et al.
Acta Neuropathologica
|
February 19, 2013
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M Fontebasso, Jeremy Schwartzentruber, Dong-Anh Khuong-Quang, et al.
Page
of 59